The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis
Pre-exposure prophylaxis (PrEP) is considered one of the five "pillars" by UNAIDS to reduce HIV transmission. Moreover, it is a tool for female self-protection against HIV, making it highly relevant to sub-Saharan regions, where women have the highest infection burden. To date, Truvada is...
Saved in:
Main Authors: | Sulav Duwal (Author), Daniel Seeler (Author), Laura Dickinson (Author), Saye Khoo (Author), Max von Kleist (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiscale Systems‐Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV‐1
by: S Duwal, et al.
Published: (2016) -
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
by: Max von Kleist, et al.
Published: (2020) -
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
by: Larru B, et al.
Published: (2014) -
Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016) -
Predicting Efavirenz Concentrations in the Brain Tissue of HIV‐Infected Individuals and Exploring their Relationship to Neurocognitive Impairment
by: Nithya Srinivas, et al.
Published: (2019)